64080-15-5

Basic information

• Product Name: 2-BROMO-4-ETHYLPHENOL
• Synonyms: 2-BROMO-4-ETHYLPHENOL
• CAS NO: 64080-15-5
• Molecular Formula: C₈H₉BrO
• Molecular Weight: 201.06046
• Mol File: 64080-15-5.mol
• Article Data: 17

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2-BROMO-4-ETHYLPHENOL(CAS DataBase Reference)
• NIST Chemistry Reference: 2-BROMO-4-ETHYLPHENOL(64080-15-5)
• EPA Substance Registry System: 2-BROMO-4-ETHYLPHENOL(64080-15-5)

Safety Data

• Hazardous Substances Data: 64080-15-5(Hazardous Substances Data)

Usage

General Description

2-Bromo-4-ethylphenol is a chemical compound with the molecular formula C8H9BrO. It is a white to off-white solid with a slight phenolic odor. This chemical is primarily used as an intermediate in the manufacture of pharmaceuticals and agrochemicals. Additionally, it is used as a precursor in organic synthesis for the production of various aromatic compounds. 2-Bromo-4-ethylphenol is considered to be a hazardous substance and should be handled and stored with care to avoid any potential health and environmental risks.

Upstream product

• 123-07-9 4-Ethylphenol 
• 7726-95-6 bromine 
• 64-19-7 acetic acid 
• 56-23-5 tetrachloromethane 

Downstream Products

• 854259-68-0 (4-ethyl-2-bromo-phenyl)-(4-chloro-benzyl)-ether 
• 854259-66-8 (4-ethyl-2-bromo-phenyl)-(4-methyl-benzyl)-ether 
• 862278-02-2 2-bromo-4-ethylphenyl acetate 
• 104132-88-9 3-<3-(4-Ethyl-2-formylphenoxy)propyl>pyridin 
• 540495-28-1 4-ethyl-3-bromo-phenol 
• 57018-12-9 2,6-dibromo-4-ethylphenol 
• 2785-89-9 4-Ethylguaiacol 
• 1836-06-2 3-bromo-4-hydroxyacetophenone 
• 1431961-42-0 2-bromo-4-hydroxy-4-ethylcyclohexa-2,5-dienone 
• 847345-47-5 4-ethyl-2-thiophen-3-yl-phenol 

Relevant articles and documents

Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use

The invention discloses compounds of Formula (I), wherein A1, R1, R2, R3, R4, and n are as defined herein. The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.

Expedient Access to 2-Benzazepines by Palladium-Catalyzed C?H Activation: Identification of a Unique Hsp90 Inhibitor Scaffold

Bioactive 2-benzazepines were accessed in an atom- and step-economical manner through a versatile palladium-catalyzed C?H activation strategy. The C?H arylation required low catalyst loading and a mild base, which was reflected by a broad scope and high functional-group tolerance. The benzotriazolodiazepinones were identified as new heat shock protein 90 (Hsp90) inhibiting lead compounds, with considerable potential for anti-cancer applications.

Palladium-catalyzed paraformaldehyde insertion: A three-component synthesis of benzofurans

An efficient procedure for 2-aroylbenzofuran preparation from 2-bromophenols, phenacyl bromides and paraformaldehyde is described. The cheap and stable paraformaldehyde served as the carbon source via an in situ formylation reaction.